Cite
HARVARD Citation
Parks, D. et al. (n.d.). SAT0223 Indirect comparative clinical effectiveness of intravenous and subcutaneous formulations of belimumab for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus with high disease activity. Annals of the rheumatic diseases. pp. 857-858. [Online].